Bailey Steffani R, Lucas Jennifer A, Holderness Heather, Lyon-Scott Kristin, Erroba Jeremy, Flocke Susan A, Overholser AnnMarie, Tindle Hilary A
Department of Family Medicine, Oregon Health & Science University, Portland, Oregon.
Department of Family Medicine, Oregon Health & Science University, Portland, Oregon.
Am J Prev Med. 2025 Mar;68(3):607-610. doi: 10.1016/j.amepre.2024.11.020. Epub 2024 Dec 4.
Primary care delivery in the United States, including tobacco treatment, was negatively impacted by the COVID-19 public health emergency, leading to pandemic-related cessation disparities. Early in the public health emergency, rates of tobacco assessment during telehealth visits were substantially lower than during in-person visits. It is unknown if these changes persisted.
Electronic health record data were extracted and analyzed in 2024 from adult patients with ≥1 primary care visit to a primary care community-based health clinic between 01/01/2019 and 05/31/2023 (N=1,792,934 patients from 541 clinics in 17 states). The monthly percentage of visits with smoking assessment (yes/no) were examined overall and by visit modality.
Prior to March 2020, <1% of visits were via telehealth. In the months following, >50% were via telehealth, leveling to 25% in the later study months. Prior to the public health emergency, >95% of all visits included smoking assessment; the highest monthly percentage after the public health emergency declaration was 77%. For in-person visits, assessments occurred at >95% of visits in each study month prior to March 2020, with subsequent percentages ranging from 46% (April 2020) to 95% (May 2023). In contrast, assessment during telehealth visits reached a maximum of 9% in late 2022.
Smoking assessment remained consistently lower during the public health emergency compared with the months prior, primarily driven by lack of assessment during telehealth visits. Concerted efforts are needed to ensure that telehealth visits are leveraged to promote equitable smoking assessment and delivery of evidence-based tobacco treatment among a patient population with high rates of tobacco use.
美国的初级医疗服务,包括烟草治疗,受到了2019冠状病毒病(COVID-19)公共卫生紧急事件的负面影响,导致了与大流行相关的戒烟差异。在公共卫生紧急事件初期,远程医疗就诊期间的烟草评估率大幅低于面对面就诊期间。目前尚不清楚这些变化是否持续存在。
2024年,从2019年1月1日至2023年5月31日期间到一家基于社区的初级保健诊所进行过≥1次初级保健就诊的成年患者中提取并分析电子健康记录数据(来自17个州541家诊所的1,792,934名患者)。总体上以及按就诊方式检查了进行吸烟评估(是/否)的就诊的月度百分比。
2020年3月之前,<1%的就诊是通过远程医疗进行的。在随后的几个月里,>50%的就诊是通过远程医疗进行的,在后期研究月份中降至25%。在公共卫生紧急事件之前,>95%的所有就诊都包括吸烟评估;公共卫生紧急事件宣布后的最高月度百分比为77%。对于面对面就诊,在2020年3月之前的每个研究月份中,>95%的就诊进行了评估,随后的百分比范围从46%(2020年4月)到95%(2023年5月)。相比之下,远程医疗就诊期间的评估在2022年末最高达到9%。
与之前的月份相比,公共卫生紧急事件期间的吸烟评估一直较低,主要原因是远程医疗就诊期间缺乏评估。需要共同努力,以确保利用远程医疗就诊来促进在烟草使用率较高的患者群体中进行公平的吸烟评估和提供循证烟草治疗。